Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 8084601 Oligomers
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
September 10, 2009
0
Date of Patent
December 27, 2011
0
Patent Application Number
12556626
0
Patent Citations Received
US Patent 12128109 Muscle targeting complexes and formulations for treating dystrophinopathies
0
US Patent 11787869 Methods of using muscle targeting complexes to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy or a disease associated with muscle weakness
US Patent 11833217 Muscle targeting complexes and uses thereof for treating dystrophinopathies
0
US Patent 11932851 Exon skipping compositions for treating muscular dystrophy
0
US Patent 11986537 Muscle targeting complexes and uses thereof for treating dystrophinopathies
0
US Patent 12005124 Muscle targeting complexes and uses thereof for treating dystrophinopathies
0
US Patent 12012460 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide
0
US Patent 11679161 Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
0
US Patent 11771776 Muscle targeting complexes and uses thereof for treating dystrophinopathies
Patent Inventor Names
Ian Graham
0
John George Dickson
0
Linda Popplewell
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
8084601
0
Patent Primary Examiner
Kimberly Chong
0
Find more entities like US Patent 8084601 Oligomers
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE